Translate page

Map Africa

May 2017 - In order to better recognise the scientific achievements in the emerging economic countries the iCMLf has recently launched a new section of the website that features key CML publications from these regions. You will find interesting articles on CML that have been published in peer-reviewed journals in the Middle East, Africa, Asia and Latin America.

The page will be updated regularly with new publications from the emerging economic regions. We also rely on your help. If you have an interesting CML paper or article from your country to share, please email to and provide us with the details. We will be happy to review your suggestion.

You can access the new ERSAP Publications page here


April 2017 - The iCMLf Diagnosis and Testing Program offers seeding grants to hematology institutions in emerging economic regions. The aim of the program is to facilitate the diagnosis, testing and long-term disease monitoring of CML patients in emerging economic regions where it is either limited, or not currently available.

Over five years the iCMLf have awarded 42 grants to enable CML diagnostics to be expanded and enhanced at a local level. This gives both physicians and patients the knowledge to make meaningful decisions on treatment. In 2017 the Foundation will again offer 10 grants with funding of up to $10,000.

Applications will close on the 30th of June 2017. Proposals are welcome to or read more for further information on how to apply.

Jorge Cortes 2013

March 2017 - Two additional presentations have recently been added to the iCMLf Virtual Education Program. These talks cover different aspects on modern diagnostics and were recorded during the ‘Clinical Symposium on Modern Diagnostics’ at the 18th Annual John Goldman Conference on CML in Houston last year. Now view presentations on

View other presentations on modern diagnostics here.

Logo Rare Disease Day

February 2017 - February 28th is Rare Disease Day! Today organizations supporting rare diseases and patients all over the world raise awareness for rare diseases aiming to improve access to treatment and care for 300 millions of people affected by rare diseases.

The outcomes for patients with CML have improved significantly over the past years thanks to new treatment options available, but there is still a lot to do to grant equal access to appropriate treatment and monitoring for patients around the world, especially in emerging economic regions– one of the core objectives of the iCMLf.

Learn more about rare disease here, courtesy of the Mesothelioma Cancer Alliance.

Make sure to get involved using #RareDiseaseDay

GoldmanPrize medal RGB reduc 
Congratulations to the recipients

February 2017 - Each year the International CML Foundation awards three prizes to recognise and reward outstanding achievements and contributions to the management and understanding of CML.

We are delighted to share the well-deserved 2017 prize recipients:

  • Rowley Prize - Professor Tessa Holyoake. This award acknowledges outstanding contributions to the understanding of the biology of CML and is awarded to Tessa Holyoake in recognition of her ground breaking work understanding and targeting CML stem cells.
  • Goldman Prize – Professor Tim Hughes. This prize recognises outstanding contributions to clinical management of CML and is awarded to Tim Hughes in recognition of his wide-ranging contributions to clinical research and CML treatment.
  • iCMLf Prize – Professor Jerry Radich. The iCMLf prize recognises outstanding contributions to improving the treatment of CML in the emerging economic regions. Jerry Radich is awarded the 2017 iCMLf prize for his dedication to developing methods to increase access to molecular monitoring in these regions.

iCMLf Forum 2016 Podium

February 2017 - Webstreams of the presentations from the iCMLf Forum for Physicians from Emerging Regions 2016 are now available to view. This year's Forum focused on 'Managing the high risk CML patient'. Presenters give the local emerging regions perspectives on each topic followed iCMLf experts and a discussion with the audience.

Topics include:

  1. Meeting the new challenges in CML therapy 
    Professor Brian Druker (USA) 
  2. Frontline therapy challenges 
    Professor Tapan Saikia (India) and Professor Andreas Hochhaus (Germany)
  3. Comorbidities when managing CML
    Dr Anthony Oyekunle (Botswana) and Dr Delphine Réa (France)